Share |


The below set of news items is a repository of all our press releases, statements, blogs and other news in chronological order.

  • 19 July 2013

    Healthcare stakeholders push for more patient choice in treating cataract

    Demographic changes mean that Europe's population is growing increasingly older and in need of more and better care. Eye conditions like cataract are among the most frequently encountered by Europe's elders and healthcare stakeholders have realised that patients must have a choice in accessing the best available treatment options. A conference on 9 July in the European Parliament brought together doctors, Commission representatives and policymakers to raise awareness on the issue. Hosted by MEP Heinz K. Becker (EPP), the conferenced launched policy recommendations on Healthcare and Active Ageing: Patient Choice in Cataract Care and shed light on a growing consensus that patient awareness of and access to ground-breaking cataract treaments must be improved.

    read more
  • 20 September 2012

    US PMA no more of a safeguard than EU CE mark yet drawbacks significant, report finds

    The US FDA's premarket authorisation system for regulating high-risk medical devices not only delays patients' access to potentially life-saving technologies but does not safeguard them against risky products any more than the EU's CE marking process.

    Moreover, it has a detrimental impact on small companies with limited resources which could cause these companies to stop operating, to the detriment of the development of innovative technologies in the US.

    read more
  • 30 May 2012

    Earthquake in Emilia Romagna, Italy

    Yesterday the Emilia Romagna region in Italy was struck by a powerful earthquake. From the latest information in the media we understand that 17 people lost their life, over 350 people were injured and more than 13,000 people rendered homeless. The images of the devastation that have been reported out of Italy are truly heart breaking. In this region also many member companies of Eucomed are located such as B. Braun, Fresenius and Sorin.

    read more
  • Brussels, 13 February 2012

    Joint European Medical Device Industry Statement on European Medical Device Regulatory Regime

    The European medical device technology industry associations strongly condemn the alleged fraudulent behavior of the French company Poly Implant Prothèse (PIP). Patient safety, public confidence, and ethical behavior should always be the top priorities of any organisation active in the healthcare industry.
    read more
  • 25 November 2011

    Malcolm Carlisle, OBE (1947 - 2011)

    Dear colleagues

    It is with great sadness that we hear of the untimely passing of Malcolm Carlisle.

    read more
  • 22 November 2011

    John Wilkinson is interviewed on Eucomed, its membership and the medtech industry at large

    Medical technology is a €95 billion industry for Europe. John Wilkinson, Eucomed Chief Executive, offers an insight into the organisation that represents 500,000 people employed by this vital sector.
    read more
  • 19 July 2011

    View our reaction to the Financial Times article (Lex) on Medical Devices

    Lex on 18th July suggested that, perhaps for the first time, the medical technology industry has seen cyclical impacts to demand arising out of the economic crisis and speculates as to whether these will continue. In my experience such cyclical events have occurred in the past but have been, as now, substantially damped versus the broader economy.
    read more
  • 25 February 2011

    European Commission objects to FDA remarks in a letter

    25 February 2011 - According to Reuters: “A transatlantic spat has erupted after a top U.S. official suggested European patients may be "guinea pigs" for medical devices with less government oversight. A senior official at the European Commission, in a letter obtained by Reuters, complained to the U.S. Food and Drug Administration this month about comments from the FDA's device chief, Dr. Jeffrey Shuren.....” For the full story please go to the Reuters website
    read more